Researcher confirms dementia and alzheimers are prostate cancer side effects of androgen deprivation therapy
WASHINGTON, D.C. – Elderly men diagnosed with prostate cancer should be discussing with their physicians and family the consequences of the now-confirmed reality that they’ll experience either dementia or alzheimer’s disease if more than 5 doses of testosterone-blocking hormones or orchiectomies are used to treat the life-shortening disease. This latest information was shared in the July 3, 2019 Journal of the American Medical Association (JAMA) from a researcher’s study of 154, 089 elderly men his team followed for 10 years after they received treatment within two years of a prostate cancer diagnosis. University of Pennsylvania Perelman School of Medicine Research Associate Professor…
